Skip to content

Columbia Ventures

  • Home
  • Team
  • Philosophy
  • Portfolio
    • Augmented Reality
    • Biomedical
    • Manufacturing
    • Real Estate Development
    • Software as a Service
    • Telecommunications
    • Past Investments
  • News
  • Contact

Bethlehem biotech company Saladax signs licensing deal with Johnson & Johnson affiliate

Read now on MCall.com • June 28, 2018

Author colventuresPosted on June 28, 2018June 29, 2018Categories BIOMEDICAL, Saladax Biomedical

Post navigation

Previous Previous post: Saladax signs licensing agreement with Janssen for antipsychotic drug testing patents
Next Next post: Bethlehem biotech company to acquire exclusive patent rights to antipsychotic drug tests

Recent News

  • Innovative eastern WA mill turns ag waste into booming business September 20, 2018
  • Saladax Biomedical welcomes new guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil therapy September 19, 2018
  • 5 Ways AR Will Change the Reality of Manufacturing September 11, 2018
Copyright © Columbia Ventures Corporation. All Rights Reserved.

News by Industry/Company

Search Site

  • Home
  • Team
  • Philosophy
  • Portfolio
    • Augmented Reality
    • Biomedical
    • Manufacturing
    • Real Estate Development
    • Software as a Service
    • Telecommunications
    • Past Investments
  • News
  • Contact
Powered by WordPress.com.